Putnam BioRevolution ETF (SYNB)

Assets	$5.07M
Expense Ratio	0.71%
PE Ratio	29.60
Shares Out	175,000
Dividend (ttm)	$0.21
Dividend Yield	0.73%
Ex-Dividend Date	Dec 5, 2024
Payout Frequency	Annual
Payout Ratio	21.52%

Volume	50
Open	28.96
Previous Close	28.92
Day's Range	28.96 - 28.96
52-Week Low	24.57
52-Week High	33.23
Beta	0.94
Holdings	35
Inception Date	Sep 29, 2022

About SYNB

Fund Home Page

The Putnam BioRevolution ETF (SYNB) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund actively invests in companies of all sizes around the globe that enable biological innovation. SYNB was launched on Sep 29, 2022 and is issued by Putnam.

• Asset Class: Equity
• Category: Health
• Stock Exchange: NYSEARCA
• Ticker Symbol: SYNB
• ETF Provider: Putnam

Top 10 Holdings

50.30% of assets

Name	Symbol	Weight
Thermo Fisher Scientific Inc.	TMO	7.20%
Corteva, Inc.	CTVA	6.51%
Novozymes A/S	NVZMY	5.98%
AbbVie Inc.	ABBV	5.02%
Bio-Rad Laboratories, Inc.	BIO	4.95%
Ascendis Pharma A/S	ASND	4.41%
NVIDIA Corporation	NVDA	4.40%
AstraZeneca PLC	AZN	4.15%
Eli Lilly and Company	LLY	3.91%
Cadence Design Systems, Inc.	CDNS	3.77%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 5, 2024	$0.2139	Dec 9, 2024
Dec 6, 2023	$0.0211	Dec 11, 2023

Performance

SYNB had a total return of -5.70% in the past year, including dividends. Since the fund's inception, the average annual return has been 5.88%.